Association of colchicine with cardiovascular outcomes in patients with acute coronary syndrome

Back

ESC2025 Premium Access

Association of colchicine with cardiovascular outcomes in patients with acute coronary syndrome

Session: Lipid-lowering and inflammation

Topic: Pharmacotherapy

Speaker: Doctor M. Tao (Hartford, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Michael Tao

Hartford Hospital, Hartford (United States of America)

0 follower

7 more presentations in this session

Non-steroidal anti-inflammatory drug use after invasive and non-invasive diagnostic procedures for coronary artery disease by the degree of disease: a Danish drug utilization study (2008-2021)

Speaker: Doctor A. Bech-Drewes (Aarhus, DK)

Healed plaque and systemic thrombogenicity in patients with chronic coronary syndrome

Speaker: Doctor D. Kinoshita (Yamagata, JP)

Effects of vitamin k2 and d3 supplementation on cardiac and systemic inflammation: a randomized controlled trial

Speaker: Doctor S. Hasific (Odense, DK)

The impact of very highly elevated lipoprotein(a) levels on the early onset, complexity, and extent of coronary artery disease

Speaker: Mr C. Coerkamp (Amsterdam, NL)

Emerging role of inflammatory pathways on coronary atherosclerotic risk in patients with chronic coronary syndromes under current treatment

Speaker: Doctor C. Caselli (Pisa, IT)

Access the full session

Lipid-lowering and inflammation

Speakers: Doctor M. Tao, Doctor A. Bech-Drewes, Doctor D. Kinoshita, Doctor S. Hasific, Mr C. Coerkamp...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources